The Impact of a Mobile Support Group on Distress and Physical Activity in Breast Cancer Survivors: Randomized, Parallel-Group, Open-Label, Controlled Trial.
RCT
breast neoplasms
mental distress
mobile apps
mobile health intervention
mobile phone
physical activity
randomized controlled trial
support group
survivorship
telemedicine
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
07 08 2023
07 08 2023
Historique:
received:
10
03
2023
accepted:
04
07
2023
revised:
06
06
2023
medline:
8
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
While mobile health apps have demonstrated their potential in revolutionizing health behavior changes, the impact of a mobile community built on these apps on the level of physical activity and mental well-being in cancer survivors remains unexplored. In this randomized controlled trial, we examine the effects of participation in a mobile health community specifically designed for breast cancer survivors on their physical activity levels and mental distress. We performed a single-center, randomized, parallel-group, open-label, controlled trial. This trial enrolled women between 20 and 60 years of age with stage 0 to III breast cancer, an Eastern Cooperative Oncology Group performance status of 0, and the capability of using their own smartphone apps. From January 7, 2019, to April 17, 2020, a total of 2,616 patients were consecutively screened for eligibility after breast cancer surgery. Overall, 202 patients were enrolled in this trial, and 186 patients were randomly assigned (1:1) to either the intervention group (engagement in a mobile peer support community using an app for tracking steps; n=93) or the control group (using the app for step tracking only; n=93) with a block size of 10 without stratification. The mobile app provides a visual interface of daily step counts, while the community function also provides rankings among its members and regular notifications encouraging physical activity. The primary end point was the rate of moderate to severe distress for the 24-week study period, measured through an app-based survey using the Distress Thermometer. The secondary end point was the total weekly steps during the 24-week period. After excluding dropouts, 85 patients in the intervention group and 90 patients in the control group were included in the analysis. Multivariate analyses showed that patients in the intervention group had a significantly lower degree of moderate to severe distress (B=-0.558; odds ratio 0.572; P<.001) and a higher number of total weekly step counts (B=0.125; rate ratio 1.132; P<.001) during the 24-week period. Engagement in a mobile app-based patient community was effective in reducing mental distress and increasing physical activity in breast cancer survivors. ClinicalTrials.gov NCT03783481; https://classic.clinicaltrials.gov/ct2/show/NCT03783481.
Sections du résumé
BACKGROUND
While mobile health apps have demonstrated their potential in revolutionizing health behavior changes, the impact of a mobile community built on these apps on the level of physical activity and mental well-being in cancer survivors remains unexplored.
OBJECTIVE
In this randomized controlled trial, we examine the effects of participation in a mobile health community specifically designed for breast cancer survivors on their physical activity levels and mental distress.
METHODS
We performed a single-center, randomized, parallel-group, open-label, controlled trial. This trial enrolled women between 20 and 60 years of age with stage 0 to III breast cancer, an Eastern Cooperative Oncology Group performance status of 0, and the capability of using their own smartphone apps. From January 7, 2019, to April 17, 2020, a total of 2,616 patients were consecutively screened for eligibility after breast cancer surgery. Overall, 202 patients were enrolled in this trial, and 186 patients were randomly assigned (1:1) to either the intervention group (engagement in a mobile peer support community using an app for tracking steps; n=93) or the control group (using the app for step tracking only; n=93) with a block size of 10 without stratification. The mobile app provides a visual interface of daily step counts, while the community function also provides rankings among its members and regular notifications encouraging physical activity. The primary end point was the rate of moderate to severe distress for the 24-week study period, measured through an app-based survey using the Distress Thermometer. The secondary end point was the total weekly steps during the 24-week period.
RESULTS
After excluding dropouts, 85 patients in the intervention group and 90 patients in the control group were included in the analysis. Multivariate analyses showed that patients in the intervention group had a significantly lower degree of moderate to severe distress (B=-0.558; odds ratio 0.572; P<.001) and a higher number of total weekly step counts (B=0.125; rate ratio 1.132; P<.001) during the 24-week period.
CONCLUSIONS
Engagement in a mobile app-based patient community was effective in reducing mental distress and increasing physical activity in breast cancer survivors.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03783481; https://classic.clinicaltrials.gov/ct2/show/NCT03783481.
Identifiants
pubmed: 37549004
pii: v25i1e47158
doi: 10.2196/47158
pmc: PMC10442738
doi:
Banques de données
ClinicalTrials.gov
['NCT03783481']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e47158Informations de copyright
©Miyeon Jung, Sae Byul Lee, Jong Won Lee, Yu Rang Park, Haekwon Chung, Yul Ha Min, Hye Jin Park, Minsun Lee, Seockhoon Chung, Byung Ho Son, Sei-Hyun Ahn, Il Yong Chung. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.08.2023.
Références
JMIR Mhealth Uhealth. 2020 May 4;8(5):e17320
pubmed: 32364508
J Cancer Educ. 2019 Feb;34(1):41-49
pubmed: 28780685
J Cancer Surviv. 2020 Feb;14(1):80-88
pubmed: 31776849
JAMA Dermatol. 2015 May;151(5):505-12
pubmed: 25629819
BMC Public Health. 2019 Jun 3;19(Suppl 2):542
pubmed: 31159752
Psychooncology. 2019 Jul;28(7):1420-1429
pubmed: 30980691
JMIR Mhealth Uhealth. 2019 Sep 04;7(9):e12882
pubmed: 31486407
Acta Oncol. 2021 Aug;60(8):968-975
pubmed: 33689553
J Natl Compr Canc Netw. 2013 May;11(5 Suppl):640-4
pubmed: 23704233
J Cancer Surviv. 2020 Aug;14(4):504-517
pubmed: 32162194
PLoS One. 2016 Jun 28;11(6):e0156370
pubmed: 27352250
J Clin Oncol. 2018 Mar 10;36(8):780-788
pubmed: 29369731
Front Oncol. 2020 Jan 10;9:1505
pubmed: 31998651
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1251-1256
pubmed: 31590156
Lancet Oncol. 2013 Jul;14(8):721-32
pubmed: 23759376
JMIR Mhealth Uhealth. 2019 Feb 28;7(2):e12209
pubmed: 30816851
JMIR Mhealth Uhealth. 2020 Mar 18;8(3):e17046
pubmed: 32186518
Int J Environ Res Public Health. 2018 Dec 13;15(12):
pubmed: 30551555
JAMA Netw Open. 2019 May 3;2(5):e194281
pubmed: 31125101
Breast Cancer Res Treat. 2008 Jul;110(1):9-17
pubmed: 17674188
CA Cancer J Clin. 2022 May;72(3):230-262
pubmed: 35294043
Stud Health Technol Inform. 2015;216:89-92
pubmed: 26262016
PLoS One. 2013;8(2):e56353
pubmed: 23418561
Psychooncology. 2015 Aug;24(8):857-70
pubmed: 25328103
Cancers (Basel). 2022 Aug 06;14(15):
pubmed: 35954479
Med Sci Sports Exerc. 2019 May;51(5):930-940
pubmed: 30694978
Am J Transl Res. 2011 Aug 15;3(4):342-50
pubmed: 21904654
Health Promot Int. 2019 Feb 1;34(1):16-27
pubmed: 28973149
CA Cancer J Clin. 2016 Jan-Feb;66(1):43-73
pubmed: 26641959
Support Care Cancer. 2021 Dec;29(12):7669-7678
pubmed: 34142280
Psychooncology. 2019 Dec;28(12):2257-2269
pubmed: 31464026
J Cancer Surviv. 2019 Aug;13(4):593-602
pubmed: 31264183
J Med Internet Res. 2019 Sep 06;21(9):13463
pubmed: 31493319
J Womens Health (Larchmt). 2012 Mar;21(3):311-8
pubmed: 22060256
J Cancer Surviv. 2015 Jun;9(2):305-38
pubmed: 25432633
Int J Behav Nutr Phys Act. 2018 Oct 30;15(1):106
pubmed: 30376857
Psychol Health. 2011 Sep;26(9):1113-27
pubmed: 21929476
J Clin Oncol. 2017 Jan;35(1):78-85
pubmed: 28034075
Support Care Cancer. 2018 Nov;26(11):3915-3923
pubmed: 29785635